As a close correlation exists between collagen-linked fluorescence and advanced glycation end product (AGE) content in skin biopsies, measuring skin autofluorescence (SAF) can be used to assess tissue deposition of AGEs. McIntyre et al. now report that increased SAF is independently associated with multiple cardiovascular and renal risk factors in patients with stage 3 chronic kidney disease, and may therefore be a useful and noninvasive method for assessing risk.
ORIGINAL RESEARCH PAPER
McIntyre, N. J. et al. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin. J. Am. Soc. Nephrol. doi:10.2215/CJN.02420311
Rights and permissions
About this article
Cite this article
Use of skin autofluorescence to assess risk. Nat Rev Nephrol 7, 607 (2011). https://doi.org/10.1038/nrneph.2011.146
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2011.146